1. Home
  2. VSH vs COGT Comparison

VSH vs COGT Comparison

Compare VSH & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vishay Intertechnology Inc.

VSH

Vishay Intertechnology Inc.

N/A

Current Price

$22.43

Market Cap

4.9B

Sector

Technology

ML Signal

N/A

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

N/A

Current Price

$26.90

Market Cap

5.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VSH
COGT
Founded
1962
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.5B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
VSH
COGT
Price
$22.43
$26.90
Analyst Decision
Buy
Strong Buy
Analyst Count
7
12
Target Price
$38.67
★ $55.82
AVG Volume (30 Days)
★ 3.1M
1.9M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
★ 1.60%
N/A
EPS Growth
★ 69.57
N/A
EPS
★ 0.63
N/A
Revenue
★ $3,069,048,000.00
$7,871,000.00
Revenue This Year
$21.51
N/A
Revenue Next Year
$15.23
$5,819.52
P/E Ratio
$39.78
★ N/A
Revenue Growth
★ 4.48
N/A
52 Week Low
$12.49
$26.36
52 Week High
$69.47
$43.73

Technical Indicators

Market Signals
Indicator
VSH
COGT
Relative Strength Index (RSI) 35.86 36.08
Support Level $21.42 N/A
Resistance Level $30.19 $37.34
Average True Range (ATR) 2.10 1.77
MACD -0.11 -0.36
Stochastic Oscillator 9.22 6.38

Price Performance

Historical Comparison
VSH
COGT

About VSH Vishay Intertechnology Inc.

Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: